EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study

A Di Leone, A Filippone, C Maggiore, M M Rossi, C Rossi, A Di Micco, Luana Forcina, A Franco, L Ionta, A Fabi, I Paris, L Scardina und 5 weitere

Breast Cancer Research and Treatment · 2025-02 · 210 (1) · 205-213

DOI: 10.1007/s10549-024-07553-x ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 04.12.2024. Verfasst von A Di Leone und 16 weiteren Autor:innen. Beteiligte Einrichtung: Breast Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo Agostino Gemell…. Hauptthemen laut MEDLINE: Breast Neoplasms, Body Composition, Neoadjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Neoadjuvant chemotherapy (NAC) has a well-established role in locally advanced or chemoresponsive breast cancers (BC). Chemotherapic regimens are effective when patients receive the optimal doses. Toxicities are common in overweight/obese patients but may occur also in normal weight counterparts. This leads to delays, reductions, or discontinuation of treatment, with impact on outcomes. Current dosing is based on body weight and predicted Body Surface Area (BSA). These parameters do not take into consideration the individual variations of fat mass (FM) and fat-free mass (FFM) that affect pharmacokinetics. Assessment of body composition (BoCo), rather than Body Mass Index (BMI), could help to better plan chemotherapy and reduce drug-related toxicities. Our aim was to analyze the correlations between body weight, anthropometric measures, BoCO, and toxicities related to NAC in non-metastatic BC patients.

Methods

This is a retrospective observational cohort study that includes 120 consecutive BC patients undergoing NAC, enrolled between May 2018 and December 2020. All patients received an evaluation of anthropometric parameters (height, weight, waist and hip circumference, BMI) and an assessment of BoCo using Segmental Multi-Frequency-Bioelectrical Impedance Analysis.

Results

A logistic regression models confirmed that a higher FM was associated with a higher rate of neurological and hematologic toxicities in protocols containing Platinum. Moreover, patients with a low FFM% have a higher risk for hematologic toxicity in protocols containing Platinum.

Conclusion

A routine assessment of BoCo, in addition to evaluation of anthropometric measures and BMI, could allow to personalize chemotherapy doses, in order to reduce chemotherapy-related toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBody CompositionNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsHematologic DiseasesHumansFemaleRetrospective StudiesMiddle AgedAdultAgedBody Mass Index

Stichwörter der Autor:innen

Body compositionBreast cancerNeoadjuvant chemotherapyPersonalized medicineToxicity

Autor:innen und Institutionen

  • Breast Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo Agostino Gemelli, 8, 00136, Rome, Italy.
  • Center for Integrative Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Breast Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo Agostino Gemelli, 8, 00136, Rome, Italy. antonio.franco@guest.policlinicogemelli.it.
  • Precision Medicine Breast Unit, Scientific Directorate, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Univesitario "A. Gemelli" IRCCS, Rome, Italy.
  • Department of Women, Children and Public Health Sciences, Fondazione Policlinico Univesitario "A. Gemelli" IRCCS, Rome, Italy.
  • Epidemiology & Biostatistics Research Core Facility, Gemelli Generator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Zitieren

APA

Di Leone, A., Filippone, A., Maggiore, C., Rossi, M. M., Rossi, C., Di Micco, A., Forcina, L., Franco, A., Ionta, L., Fabi, A., Paris, I., Scardina, L., Sanchez, A. M., Pafundi, P. C., Franceschini, G., Masetti, R., & Magno, S. (2025). The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study. Breast Cancer Research and Treatment, 210(1), 205-213. https://doi.org/10.1007/s10549-024-07553-x

Vancouver

Di Leone A, Filippone A, Maggiore C, Rossi MM, Rossi C, Di Micco A, et al. The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study. Breast Cancer Research and Treatment. 2025;210(1):205-213. doi:10.1007/s10549-024-07553-x

BibTeX
@article{DiLeone2025,
  author = {Di Leone, A and Filippone, A and Maggiore, C and Rossi, M M and Rossi, C and Di Micco, A and Forcina, Luana and Franco, A and Ionta, L and Fabi, A and Paris, I and Scardina, L and Sanchez, A M and Pafundi, P C and Franceschini, G and Masetti, R and Magno, S},
  title = {The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  volume = {210},
  number = {1},
  pages = {205--213},
  doi = {10.1007/s10549-024-07553-x}
}
Kostenlos starten →